Harnessing AI to Address Global Health Challenges with Cambridge Consultants

Title

Harnessing AI to Address Global Health Challenges with Cambridge Consultants

In the Press - Sep. 25, 2019

The innovation specialists at Cambridge Consultants have developed BacillAi, a concept system that harnesses Artificial Intelligence (AI) and standard, low-cost hardware to improve treatment monitoring of tuberculosis (TB) in resource-limited countries. With TB the second largest cause of death by infectious disease in the developing world, the BacillAi system is part of Cambridge Consultants’ continuing mission to move AI beyond the hype, addressing practical, high-impact challenges and improving lives on a global scale.

Upcoming Events

Sep. 22, 2021

Grocery Shop

Other News

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

Congratulations to our colleagues at Cambridge Consultants, who today announced their role in the development of the first fully at-home, prescription-free COVID-19 test to receive U.S. Government Emergency Use Authorization.